Title: Larotinib in Patients with Advanced and Previously Treated Esophageal Squamous Cell
Carcinoma with Epidermal Growth Factor Receptor Overexpression or Amplification: An Open-
Label, Multicenter Phase 1b Study
Version: 2 Date: 02 Oct 2021
Reviewer's report:
The authors responded accurately to the reviewer's comments.
Title: Larotinib in Patients with Advanced and Previously Treated Esophageal Squamous Cell
Carcinoma with Epidermal Growth Factor Receptor Overexpression or Amplification: An Open-
Label, Multicenter Phase 1b Study
Version: 2 Date: 02 Oct 2021
Reviewer's report:
The authors responded accurately to the reviewer's comments.
Please review this paper.
user
Title: Larotinib in Patients with Advanced and Previously Treated Esophageal Squamous Cell
Carcinoma with Epidermal Growth Factor Receptor Overexpression or Amplification: An Open-
Label, Multicenter Phase 1b Study
Version: 2 Date: 02 Oct 2021
Reviewer's report:
The authors responded accurately to the reviewer's comments.
assistant